# Nexium Capsules Non-steroidal Anti-inflammatory Drug (NSAID) Specific Clinical Experience Investigation

> **NCT01562600** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 1634 (actual)

## Conditions studied

- Gastric Ulcer
- Duodenal Ulcer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01562600
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04-19
- **Primary completion:** 2015-08-27
- **Final completion:** 2015-08-27
- **Target enrollment:** 1634 (ACTUAL)
- **Last updated:** 2019-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01562600

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01562600, "Nexium Capsules Non-steroidal Anti-inflammatory Drug (NSAID) Specific Clinical Experience Investigation". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT01562600. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*